| Name | Title | Contact Details |
|---|
NC Board of Nursing is a Raleigh, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Premium Level: Premium Lifestyle Founded in 2012 by Jason Camper and Paul Gravette, Le-Vel formulates and sells nutritional/health and wellness products like the Le-Vel Thrive product line. Le-Vel is the only health and wellness company that uses cloud-based technology for its day-to-day business operations. Le-Vel`s cloud-based infrastructure enables the company to keep overhead to a minimum while increasing commissions and opportunities for its independent Brand Promoters and putting more money into the Le-Vel THRIVE product line. Some of the products in the Le-Vel line include: Thrive Premium Lifestyle DFT (Derma Fusion Technology), Thrive Premium Lifestyle Capsules, Thrive Premium Lifestyle Mix, Activate, Boost, Balance, Black Label, Café, DFT Duo, Expand, FORM, Thrive Kids, Move, Thrive PRO, Rest, Pure, BURN, THRIVEFIT and Thrive Bites. Le-Vel and the Le-Vel Thrive brand have more than 10 million customers and brand promoters. The company ships within the United States, Canada, Australia, New Zealand, the United Kingdom, and Mexico. In less than 7 years in business, Le-Vel reached $2 billion in lifetime sales.
Oneida Healthcare Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Oneida Healthcare Center is based in Oneida, NY. You can find more information on Oneida Healthcare Center at www.oneidahealthcare.org
Five Seasons Sports Club is a Dayton, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
TherOx, Inc. (TherOx) is a private, venture-financed medical device company based in Irvine, California, dedicated to elevating the standard of care for treatment of heart attack patients. A heart attack is caused when an artery in the heart becomes blocked. Current treatment of heart attack is to reestablish blood flow in the blocked artery as quickly as possible. Typically, this is done with a combination of medication and a percutaneous coronary intervention (PCI) which may include the placement of a (intracoronary) stent. PCI successfully restores blood flow, but damage to the patient’s heart remains. Blood flow in the microvasculature downstream from the blockage is compromised, and critical heart muscle tissue is damaged – or infarcted – due to oxygen deprivation brought on by the heart attack. The intent of SuperSaturated Oxygen (SSO2) Therapy from TherOx is to salvage damaged heart tissue by placing a high concentration of oxygen (~760 – 1,000 mmHg, or 5 – 7 times normal levels) into the patient’s blood plasma and delivering it directly to the area impacted by the heart attack. SSO2 Therapy serves as a complement to PCI and stenting. Immediately following the interventional procedure, proprietary technology from TherOx mixes a pre-specified concentration of “SuperOxygenated” saline solution with the patient’s blood to produce SuperOxygenated blood. The SuperOxygenated blood is then delivered through a catheter to the oxygen deficient tissue. Company research has confirmed in clinical studies that SuperSaturated Oxygen Therapy has the potential to reverse ischemia and may resuscitate tissue that may otherwise die. SSO2 Therapy circulates the patient`s own blood via the existing arterial access site used for the stenting procedure. Thus, no new access site is required. The TherOx DownStream System and DownStream Cartridge bear the CE Mark but are not available for commercial distribution in the EU at this time.